EcoDrugPlus

Arachidonate 15-Lipoxygenase

Ensembl ID : ENSNFUG00015012795
Gene Symbol: ALOX15
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSNFUG00015018618
Gene Symbol: ALOX5A
1 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSNFUG00015013589
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSNFUG00015018074
Gene Symbol: LOC107396339
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSNFUG00015023914
Gene Symbol: AVPR1A
1 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSNFUG00015005888
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSNFUG00015020000
Gene Symbol: AVPR2
1 Cross references
148 Possible Orthologues:

Aromatase

Ensembl ID : ENSNFUG00015023830
Gene Symbol: LOC107388638
3 Cross references
244 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSNFUG00015022558
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSNFUG00015001956
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSNFUG00015015141
Gene Symbol: LOC107385866
3 Cross references
216 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSNFUG00015008648
Gene Symbol: LOC107386754
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).